EUVIMEDEUVIMED entdecken
Open Access

Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients

Abdul Salam, Asif Ali, Umar Nishan iD, Noaman Khan, Mohamed A Ibrahim, Zafar Iqbal, Nawshad Muhammad, Anum Fayyaz, Fawad Muhammad, Abdul Mateen, Zhiyuan Wu, Saifullah Afridi iD

ACS Pharmacology & Translational Science · 08.11.2024 · 7 (11) · 3585-3591

DOI: 10.1021/acsptsci.4c00490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 07.10.2024. Verfasst von Abdul Salam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology, Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: King Saud University, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Histopathology, Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan.
  • Department of Chemistry, Kohat University of Science and Technology, Kohat 26000, Khyber Pukhtunkhwa, Pakistan.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Surgery, College of Medicine, King Saud University, P.O. Box 7805, Riyadh 11472, Saudi Arabia.
  • Department of Dental Materials, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan.
  • Pathology Department, Rehman Medical College, Peshawar 25000, Khyber Pukhtunkhwa, Pakistan.

ORCID-Profile: Umar Nishan, Saifullah Afridi

Förderung

  • King Saud University
  • National Natural Science Foundation of China

Zitieren

APA

Salam, A., Ali, A., Nishan, U., Khan, N., Ibrahim, M. A., Iqbal, Z., Muhammad, N., Fayyaz, A., Muhammad, F., Mateen, A., Wu, Z., & Afridi, S. (2024). Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients. ACS Pharmacology & Translational Science, 7(11), 3585-3591. https://doi.org/10.1021/acsptsci.4c00490

Vancouver

Salam A, Ali A, Nishan U, Khan N, Ibrahim MA, Iqbal Z, et al. Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients. ACS Pharmacology & Translational Science. 2024;7(11):3585-3591. doi:10.1021/acsptsci.4c00490

BibTeX
@article{Salam2024,
  author = {Salam, Abdul and Ali, Asif and Nishan, Umar and Khan, Noaman and Ibrahim, Mohamed A and Iqbal, Zafar and Muhammad, Nawshad and Fayyaz, Anum and Muhammad, Fawad and Mateen, Abdul and Wu, Zhiyuan and Afridi, Saifullah},
  title = {Investigation of Programmed Death Ligand-1 as a New Prognostic Biomarker in Pancreatic Cancer Patients},
  journal = {ACS Pharmacology & Translational Science},
  year = {2024},
  volume = {7},
  number = {11},
  pages = {3585--3591},
  doi = {10.1021/acsptsci.4c00490}
}
Kostenlos starten →